Vicarious Surgical Q3 2026 Earnings Date & Estimates

Vicarious Surgical (OTCMKTS:RBOT), Inc. is a technology company developing robotic-assisted surgical systems. Its principal product is the Vicarious Surgical System, a single-port robotic platform designed to enable surgeons to perform minimally invasive procedures through a small incision. The system combines miniature instruments, a high-resolution camera and digital controls intended to provide surgeons with an immersive view of the operating field and precise instrument control.

The company’s technology is aimed initially at general surgery applications, including procedures performed within the abdominal cavity. Vicarious Surgical has focused on developing a compact robotic system that can provide multi-axis instrument movement and visualization while potentially reducing the size and complexity of surgical access. Its products remain subject to regulatory review and authorization, and the company’s activities have primarily involved research, development and clinical evaluation rather than broad commercial deployment.

Vicarious Surgical was founded in 2014 and became a publicly traded company in 2021 through a business combination with D8 Holdings Corp. The company is based in Waltham, Massachusetts, and has concentrated its regulatory and development efforts in the United States. Co-founder Adam Sachs has served as the company’s chief executive officer and has been involved in guiding the development of its robotic surgery platform.